Agenda/Scientific Program
Keynote Speakers
Valérie Gabelica currently serves as the Research Director at the European Institute of Chemistry and Biology (IECB - CNRS, Inserm and University of Bordeaux). She studied chemistry and obtained her PhD in Sciences in 2002 at the University of Liège. After a postdoc in Frankfurt as Humboldt fellow, she rejoined the Mass Spectrometry Laboratory in Liège where she obtained an FNRS research associate position in October 2005.
She joined the IECB in 2013 with the support of an Atip-Avenir grant and became an Inserm research director (DR2) in December 2013. She obtained an ERC Consolidator grant in 2014. Her main research interests are fundamental aspects of mass spectrometry and its application to non-covalent complexes in general, and nucleic acid complexes in particular, with research themes spanning from physical chemistry to biophysics and structural chemistry and biology.
Prof. dr. Wouter Roos obtained a PhD in biophysics in Heidelberg and after a post-doc period at the Max-Planck-Institut für Metallforschung (Stuttgart) and Institut Curie (Paris) he went to the Vrije Universiteit Amsterdam to focus on Physical Virology techniques and approaches. In particular he studied (and still studies) material properties of viruses using Atomic Force Microscopy (AFM).
In 2015 he accepted the chair in Molecular Biophysics at the Zernike Institute, Rijksuniversiteit Groningen. Here Roos is heading a research group focusing on mechanics and dynamics at molecular to cellular length scales, including studies on viral self-assembly and mechanics, extra-cellular vesicles and membrane proteins. These questions are addressed with an interdisciplinary team where people with backgrounds in various disciplines of life sciences, including physics, chemistry and biology, combine forces to tackle the challenges that come up while elucidating the fascinating mechanisms that govern life processes.
Short Course: Characterization of Biopharmaceuticals
This pre-conference course addresses the different aspects which are relevant for the characterization of biopharmaceutical products according to regulatory guidelines and expectations.
Thank You for Joining Us
We appreciate your participation in AT Europe 2023 on 9-12 May 2023.
